Explore

Trendline Trendline
Kessler Topaz Meltzer Check, LLP Urges Soleno Therapeutics Investors to Join Class Action Lawsuit

Kessler Topaz Meltzer Check, LLP Urges Soleno Therapeutics Investors to Join Class Action Lawsuit

Kessler Topaz Meltzer Check, LLP Urges Soleno Therapeutics Investors to Join Class Action Lawsuit
Trendline Trendline
Gilead Sciences Extends Tender Offer for Arcellx Acquisition

Gilead Sciences Extends Tender Offer for Arcellx Acquisition

Gilead Sciences Extends Tender Offer for Arcellx Acquisition
Trendline Trendline
Novocure to Announce First Quarter 2026 Financial Results Amidst Oncology Innovations

Novocure to Announce First Quarter 2026 Financial Results Amidst Oncology Innovations

Novocure to Announce First Quarter 2026 Financial Results Amidst Oncology Innovations
Trendline Trendline
Eli Lilly Gains FDA Approval for Oral Weight-Loss Pill, Boosting Market Value

Eli Lilly Gains FDA Approval for Oral Weight-Loss Pill, Boosting Market Value

Eli Lilly Gains FDA Approval for Oral Weight-Loss Pill, Boosting Market Value
Trendline Trendline
Novocure to Announce First Quarter 2026 Financial Results with Webcast

Novocure to Announce First Quarter 2026 Financial Results with Webcast

Novocure to Announce First Quarter 2026 Financial Results with Webcast
Reuters Reuters
Factbox-Global pharma companies that have publicly announced Trump drug pricing agreements

Factbox-Global pharma companies that have publicly announced Trump drug pricing agreements

April 2 (Reuters) - U.S. President Donald Trump secured agreements with 16 major pharmaceutical companies to bring U.S. prescription drug prices in line with those paid in other developed nations in exchange for three-year exemptions from tariffs on drug imports.
Trendline Trendline
Novo Nordisk Claims Wegovy Pill Outperforms Eli Lilly's Foundayo in Weight Loss

Novo Nordisk Claims Wegovy Pill Outperforms Eli Lilly's Foundayo in Weight Loss

Novo Nordisk Claims Wegovy Pill Outperforms Eli Lilly's Foundayo in Weight Loss
Trendline Trendline
Agios Plans Accelerated FDA Filing for Sickle Cell Therapy Amid Mixed Trial Results

Agios Plans Accelerated FDA Filing for Sickle Cell Therapy Amid Mixed Trial Results

Agios Plans Accelerated FDA Filing for Sickle Cell Therapy Amid Mixed Trial Results
Trendline Trendline
Orionis Biosciences Appoints Dr. Giulio Draetta as Chief Strategy Officer Amid Growth

Orionis Biosciences Appoints Dr. Giulio Draetta as Chief Strategy Officer Amid Growth

Orionis Biosciences Appoints Dr. Giulio Draetta as Chief Strategy Officer Amid Growth
Trendline Trendline
CVS Expands with New 'Apothecary-Style' Pharmacy Locations Nationwide

CVS Expands with New 'Apothecary-Style' Pharmacy Locations Nationwide

CVS Expands with New 'Apothecary-Style' Pharmacy Locations Nationwide
Trendline Trendline
Retirement Systems of Alabama Acquires Significant Stake in Hecla Mining Company

Retirement Systems of Alabama Acquires Significant Stake in Hecla Mining Company

Retirement Systems of Alabama Acquires Significant Stake in Hecla Mining Company
Trendline Trendline
US Megadeals Surge 319% as Corporate Consolidation Returns with a Vengeance

US Megadeals Surge 319% as Corporate Consolidation Returns with a Vengeance

US Megadeals Surge 319% as Corporate Consolidation Returns with a Vengeance